|
Market Closed -
Euronext Paris
03:55:00 27/10/26 am AEDT
|
After hours 05:54:05 am | |||
| 1.278 EUR | -3.47% |
|
1.274 | -0.31% |
| 13/10 | Crossject: No market launch of Zepizure before H127 at best | AL |
| 25/09 | Crossject: H126. Quid novi sub sole? Not much. | AL |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Drug Delivery Systems
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 80.72M | - | - | |||
| 179B | |||||
| 118B | |||||
| 117B | |||||
| 93.26B | |||||
| 63.16B |
- Stock Market
- Stocks
- ALCJ Stock
- Charts Crossject
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
